Literature DB >> 25023628

Phenotypic and functional activation of hyporesponsive KIRnegNKG2Aneg human NK-cell precursors requires IL12p70 provided by Poly(I:C)-matured monocyte-derived dendritic cells.

Shane A Curran1, Emanuela Romano2, Michael G Kennedy2, Katharine C Hsu3, James W Young4.   

Abstract

A functionally responsive natural killer (NK)-cell repertoire requires the acquisition of inhibitory NKG2A and killer immunoglobulin-like receptors (KIR) through pathways that remain undefined. Functional donor NK cells expressing KIRs for non-self class I MHC ligands contribute to a positive outcome after allogeneic hematopoietic stem cell transplantation (alloHSCT) by targeting HLA-matched recipient leukemic cells. Insofar as circulating donor conventional dendritic cells (DC) reconstitute with comparable kinetics with donor NK cells after alloHSCT, we used hyporesponsive KIRnegNKG2Aneg precursor cells to evaluate how specific DC subtypes generate a functionally active NK-cell repertoire. Both monocyte-derived DCs (moDC) and Langerhans-type DCs (LC) induce KIRnegNKG2Aneg precursor cells to express the inhibitory receptors NKG2A and KIR, without requiring cell proliferation. Poly(I:C)-matured moDCs significantly augmented the expression of NKG2A, but not KIR, in an IL12p70-dependent manner. Although all DC-stimulated KIRnegNKG2Aneg cells were able to acquire cytolytic activity against class I MHC-negative targets, the ability to secrete IFNγ was restricted to cells that were stimulated by IL12p70-producing, poly(I:C)-matured moDCs. This critical ability of poly(I:C)-matured moDCs to provide IL12p70 to developing KIRnegNKG2Aneg precursors results in a dom4inant, multifunctional, NKG2Apos NK-cell population that is capable of both cytolysis and IFNγ production. Poly(I:C)-matured moDCs are, therefore, the most effective conventional DC subtype for generating a functionally competent NK-cell repertoire by an IL12p70-dependent mechanism. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023628      PMCID: PMC4185245          DOI: 10.1158/2326-6066.CIR-14-0054-T

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  47 in total

Review 1.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

Review 2.  Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity.

Authors:  Marco Rossi; James W Young
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

3.  An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.

Authors:  Nicolas Dulphy; Philippe Haas; Marc Busson; Stéphanie Belhadj; Régis Peffault de Latour; Marie Robin; Maryvonnick Carmagnat; Pascale Loiseau; Ryad Tamouza; Catherine Scieux; Claire Rabian; James P Di Santo; Dominique Charron; Anne Janin; Gérard Socié; Antoine Toubert
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

4.  NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Authors:  Andreas T Björklund; Marie Schaffer; Cyril Fauriat; Olle Ringdén; Mats Remberger; Christina Hammarstedt; A John Barrett; Per Ljungman; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-01-22       Impact factor: 22.113

5.  Education of hyporesponsive NK cells by cytokines.

Authors:  Kerstin Juelke; Monica Killig; Andreas Thiel; Jun Dong; Chiara Romagnani
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

6.  NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

Authors:  Bree Foley; Sarah Cooley; Michael R Verneris; Julie Curtsinger; Xianghua Luo; Edmund K Waller; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

Review 7.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

8.  HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Authors:  Jeffrey M Venstrom; Gianfranco Pittari; Ted A Gooley; Joseph H Chewning; Stephen Spellman; Michael Haagenson; Meighan M Gallagher; Mari Malkki; Effie Petersdorf; Bo Dupont; Katharine C Hsu
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

9.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.

Authors:  Niklas K Björkström; Peggy Riese; Frank Heuts; Sandra Andersson; Cyril Fauriat; Martin A Ivarsson; Andreas T Björklund; Malin Flodström-Tullberg; Jakob Michaëlsson; Martin E Rottenberg; Carlos A Guzmán; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-08-09       Impact factor: 22.113

10.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  4 in total

1.  Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.

Authors:  Shane A Curran; Justin A Shyer; Erin T St Angelo; Lillian R Talbot; Sneh Sharma; David J Chung; Glenn Heller; Katharine C Hsu; Brian C Betts; James W Young
Journal:  Cancer Immunol Res       Date:  2016-12-06       Impact factor: 11.151

2.  Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.

Authors:  Shaoyu Li; Yuejie Zhu; Song Wang; Yujiao Li; Nannan Pang; Mengting An; Fengbo Zhang; Jianbing Ding
Journal:  Mol Biol Rep       Date:  2022-06-17       Impact factor: 2.742

3.  Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.

Authors:  Brian C Betts; David Bastian; Supinya Iamsawat; Hung Nguyen; Jessica L Heinrichs; Yongxia Wu; Anusara Daenthanasanmak; Anandharaman Veerapathran; Alison O'Mahony; Kelly Walton; Jordan Reff; Pedro Horna; Elizabeth M Sagatys; Marie C Lee; Jack Singer; Ying-Jun Chang; Chen Liu; Joseph Pidala; Claudio Anasetti; Xue-Zhong Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-30       Impact factor: 11.205

Review 4.  Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.

Authors:  Benedikt Jacobs; Veronika Gebel; Lukas Heger; Victoria Grèze; Hansjörg Schild; Diana Dudziak; Evelyn Ullrich
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.